Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Diseases of the Colon and Rectum|July 26, 2023
Local Regrowth and the Risk of Distant Metastases Among Patients Undergoing Watch-and-Wait for Rectal Cancer: What Is the Best Control Group? Multicenter Retrospective StudyGuilherme Pagin São Julião, Laura M Fernández, Bruna Borba Vailati, et al.
Diseases of the Colon and Rectum|June 17, 2025
Partial Responders to Neoadjuvant Therapy and the Risk of Distant Metastases: Longer Intervals to Definitive Resection Is Not a Risk FactorLaura M Fernandez, Bruna Borba Vailati, Guilherme Pagin São Julião, et al.
Cancers|April 26, 2025
An International Multicentre Retrospective Cohort Study Evaluating Robot-Assisted Total Mesorectal Excision in Experienced Dutch, French, and United Kingdom Centres-The EUREKA CollaborativeRitch T J Geitenbeek, Charlotte M S Genders, Christophe Taoum, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|January 17, 2022
Is it safe to perform an anastomosis for rectal cancer after prostate cancer? A multicentre study of 126 patients from the GRECCAR groupZaher Lakkis, Alexandre Doussot, Simone Manfredelli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 6, 2020
Comparison of 18FDG-PET/CT and conventional follow-up methods in colorectal cancer: A randomised prospective studyJacques Monteil, Valerie Le Brun-Ly, Florent Cachin, et al.
Surgery|January 26, 2022
Nonmetastatic ypt0 rectal cancer after neoadjuvant treatment and total mesorectal excision: Lessons from a retrospective multicentric cohort of 383 patientsMaxime K Collard, Eric Rullier, Yves Panis, et al.
Annales De Pathologie|December 17, 2011
[Locally advanced rectal cancer management: which role for the pathologist in 2011?]Frédéric Bibeau, Anne Rullier, Marie-Françoise Jourdan, et al.
Lancet (London, England)|June 12, 2017
Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trialEric Rullier, Philippe Rouanet, Jean-Jacques Tuech, et al.
Annals of Surgery|September 16, 2016
To Drain or Not to Drain Infraperitoneal Anastomosis After Rectal Excision for Cancer: The GRECCAR 5 Randomized TrialQuentin Denost, Philippe Rouanet, Jean-Luc Faucheron, et al.
The Lancet. Gastroenterology & Hepatology|February 12, 2020
Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trialEric Rullier, Véronique Vendrely, Julien Asselineau, et al.
Pageof 9